Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3
- DOI
- 10.1016/j.toxrep.2019.04.006
- Published
- 2019
- Container
- Toxicology Reports
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.toxrep.2019.04.006,
title = {Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3},
author = {Laura Tornatore and Daria Capece and Daniel D'Andrea and Federica Begalli and Daniela Verzella and Jason Bennett and Gary Acton and Elizabeth A. Campbell and James Kelly and Michael Tarbit and Nigel Adams and Selina Bannoo and Antonio Leonardi and Annamaria Sandomenico and Domenico Raimondo and Menotti Ruvo and Angela Chambery and Metod Oblak and Magda J. Al-Obaidi and Richard S. Kaczmarski and Ian Gabriel and Heather E. Oakervee and Martin F. Kaiser and Ashutosh Wechalekar and Reuben Benjamin and Jane F. Apperley and Holger W. Auner and Guido Franzoso},
year = {2019},
journal = {Toxicology Reports},
doi = {10.1016/j.toxrep.2019.04.006},
url = {https://doi.org/10.1016/j.toxrep.2019.04.006}
}RIS
TY - JOUR TI - Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3 AU - Laura Tornatore AU - Daria Capece AU - Daniel D'Andrea AU - Federica Begalli AU - Daniela Verzella AU - Jason Bennett AU - Gary Acton AU - Elizabeth A. Campbell AU - James Kelly AU - Michael Tarbit AU - Nigel Adams AU - Selina Bannoo AU - Antonio Leonardi AU - Annamaria Sandomenico AU - Domenico Raimondo AU - Menotti Ruvo AU - Angela Chambery AU - Metod Oblak AU - Magda J. Al-Obaidi AU - Richard S. Kaczmarski AU - Ian Gabriel AU - Heather E. Oakervee AU - Martin F. Kaiser AU - Ashutosh Wechalekar AU - Reuben Benjamin AU - Jane F. Apperley AU - Holger W. Auner AU - Guido Franzoso PY - 2019 JO - Toxicology Reports DO - 10.1016/j.toxrep.2019.04.006 UR - https://doi.org/10.1016/j.toxrep.2019.04.006 ER -
APA
Tornatore, L., Capece, D., D'Andrea, D., Begalli, F., Verzella, D., Bennett, J., Acton, G., Campbell, E. A., Kelly, J., Tarbit, M., Adams, N., Bannoo, S., Leonardi, A., Sandomenico, A., Raimondo, D., Ruvo, M., Chambery, A., Oblak, M., Al-Obaidi, M. J., Kaczmarski, R. S., Gabriel, I., Oakervee, H. E., Kaiser, M. F., Wechalekar, A., Benjamin, R., Apperley, J. F., Auner, H. W., & Franzoso, G. (2019). Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3. Toxicology Reports. https://doi.org/10.1016/j.toxrep.2019.04.006
Source records
- crossref · retrieved 2026-09-25T15:33:04.795Z